Molecular Pathogenesis of Brain Damage and Gene Therapy in Genetic Leukodystrophy
Molecular Pathogenesis of Brain Damage and Gene Therapy in Genetic Leukodystrophy
批准号:
11470176
负责人:
ETO Yoshikatsu
金额:
$9.54万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001
中文摘要
1. 1)利用Krabbe globoid Cell Leukodystrophy (GLD)动物模型,试图找出抽搐小鼠白质营养不良的原因。斑痉挛法证实,神经细胞损伤的原因可能是细胞内钙的内流。细胞内钙的增加导致细胞蛋白酶的激活,从而对神经细胞造成损伤。2)我们研究了异色性脑白质营养不良的临床表型和基因型,并在2例MLD中发现了新的基因型。此外,我们还发现G99D突变为神经严重型,占日本mld所有基因型的50%。3)日本干燥拉尔松综合征患者具有日本特有的基因型。4)我们研究了法布里病的基因型鉴定,分别为L16H、A37V、W209X、342QIVS-1-1等。遗传白质营养不良的细胞治疗和基因治疗采用Twitcher小鼠和Sly小鼠进行基因治疗和细胞治疗。1)在胎儿期,将腺病毒载体注入Twitcher小鼠脑室内。注射病毒载体后,治疗动物的球状细胞数量减少。同时,治疗动物的精神素含量降低。2)将人胎脑提取的神经干细胞注射到Sly小鼠脑内,减少了Sly小鼠脑内积累的化合物。这些数据表明,神经干细胞对于治疗这些神经突变的中枢神经系统病变是有效的。3)间充质干细胞注入Sly小鼠后,其储存物质减少,对神经系统小鼠有效。
英文摘要
1. Pathogenesis of Leukodystrophy in Globoide Cell Leukodystrophy and Other1) Using animal model of Krabbe globoid cell leukodystrophy(GLD), we tried to identified the cause of leukodytrophy in twitcher mice. The cause of neural cell damage might be caused by the influx of intracellular calcium in such mice which was demonstrated by patch cramp method. The increased intracellular calcium resulted in the activation of cellular protease and hense damage the neural cells.2) We studied the clinical phnotype and genotype in metachromatic leukodystrophy and also identified novel genotype in two cases with MLD. Furthermore, we demonstrated that the G99D mutation was neruological severe type and consisted of 50% of all genotype of Japanese MLD.3) Japanese patients with Sjogren Larrson syndrome shows particular genotype in Japanese.4) We studied the genotype identifications in Fabry disease which were L16H, A37V, W209X, 342QIVS-1-1 etc.2. Cell therapy and gene therapy in genetic leukodystrophyGene therapy and cell therapy were carried out using Twitcher mice and Sly Mice.1) Twitcher mice were treated with adenovirus vector which was administered into intraventricle, during fetal period. The number of globoid cells were decreased in treated animals after the administration of viral vetor. Simultaneously, the amount of psychosine was decreased in treated animals.2) Neural stem cells obtained fromhuman fetal brains were injected into Sly mice brain and the accumulated compounds in Sly mice were decreased. The data suggest that neural stem cells were effective for the treatment of The CNS involvement in these neurological mutants.3) Injection of mesenchymal stem cells into Sly mice showed decreased storage Materials and effective for neurological mice.
期刊论文(80)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kimura T, Ohashi T, Eto Y, et al.: "The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial・・・"Cancer. 92. 2555-2561 (2001)
Kimura T、Ohashi T、Eto Y 等人:“FGFR3 基因致死性发育不良突变的发生率在低级别或浅表性癌症中较高……”癌症。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Watabe K, Ida H, Eto Y, et al: "Establishment and characterization of immortalized Schwann cells from murine model of Nieman-Pick disease C(spm/spm)"J Peripheral Nervous System. 6. 85-94 (2001)
Watabe K、Ida H、Eto Y 等人:“来自尼曼匹克病 C(spm/spm) 小鼠模型的永生化雪旺细胞的建立和表征”J 周围神经系统。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oishi K., , Ida H., Eto Y., et al.: "Clinical and molecular of Japanese patients with neuronal・・・"Molecular Genetics and Metabolism. 66. 344-348 (1999)
Oishi K., , Ida H., Eto Y., et al.:“日本神经元患者的临床和分子......”分子遗传学和代谢 66. 344-348 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Watabe K., Ohashi T., Sakamoto T., Kawazoe Y., Takeshima T., Oyanagi K., Inoue K., Eto Y., and Kim S.U.: "Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor."Journal of Neuroscience R
Watabe K.、Ohashi T.、Sakamoto T.、Kawazoe Y.、Takeshima T.、Oyanagi K.、Inoue K.、Eto Y. 和 Kim S.U.:“通过胶质细胞腺病毒基因转移来拯救受损的成年大鼠脊髓运动神经元
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Eto Y, Ohashi T: "Gene therapy/ cell therapy for lysosomal strange disease."J Inhert Metab Dis. 23(3). 293-298 (2000)
Eto Y、Ohashi T:“溶酶体奇怪疾病的基因疗法/细胞疗法。”J Inhert Metab Dis。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 39 条
Anti-CD3 antibody induced immune tolerance to infused enzyme in enzyme replacement therapy for lysosomal storage disease
-
批准号:21591333
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:ETO Yoshikatsu
-
依托单位:
Immune tolerance induction in enzyme replacement therapy for lysosomal storage diseases
-
批准号:19591223
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:ETO Yoshikatsu
-
依托单位:
Development of novel therapy and elucidation of pathophysiology for genetic leukodystrophy
-
批准号:14370252
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2002
-
负责人:ETO Yoshikatsu
-
依托单位:
Prenatal Diagnosis of Ingenited Metabolic Disorders Using Maternal Blood
-
批准号:11557061
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.1万
-
财政年份:1999
-
负责人:ETO Yoshikatsu
-
依托单位:
Studies for Gene Therapy of Sphingolipidosis
-
批准号:10044321
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$3.39万
-
财政年份:1998
-
负责人:ETO Yoshikatsu
-
依托单位:
The cause of neuropathochemistry of inherited Neurodegeneration
-
批准号:08457232
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.8万
-
财政年份:1996
-
负责人:ETO Yoshikatsu
-
依托单位:
Modified enzyme which target to neuronal cells to cross blood brain barrier
-
批准号:02557042
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$3.26万
-
财政年份:1989
-
负责人:ETO Yoshikatsu
-
依托单位:
Pathogenesis of Multiple Sulfatase Deficiency
-
批准号:01570550
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1989
-
负责人:ETO Yoshikatsu
-
依托单位:
Molecular and biochemical analysis of inherited degernerative brain disorder
-
批准号:61480223
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:1986
-
负责人:ETO Yoshikatsu
-
依托单位:
海外基金